The Ministry of Commerce, in collaboration with two additional departments, has unveiled the Action Plan for Leveraging Foreign Investment to Bolster Stability and Foster Excellence. This plan outlines a series of initiatives aimed at bolstering foreign investment in China's pharmaceutical sector, driving its high-quality growth. Key measures encompass the exploration and introduction of comprehensive guidelines for the cross-border segmented production of chemical pharmaceuticals, fostering the expansion of pilot schemes for openness in biotechnology and fully foreign-owned hospitals. Furthermore, it supports insurance companies in integrating a wider array of innovative pharmaceuticals and medical devices into their commercial insurance offerings. Additionally, the plan includes steps to streamline the entry of pharmaceuticals produced by foreign-invested enterprises into retail drug channels, ensuring smoother market access.